由MK-677引起的肝毒性
Era Cobani1, Md Shahnoor Amin2, Muneer Hasso2
1Wayne State University School of Medicine, Detroit, Michigan, USA gh5767@wayne.edu.
BMJ case reports
|July 17, 2025
概括
增长激素分泌剂MK-677 (伊布塔摩伦) 在补充剂中很受欢迎. 本案例研究强调了一例罕见的肝损伤 (透视炎) 在一个健康的男性在使用MK-677两个月后.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- MK-677 (伊布塔莫伦) 是一种流行的口服生长激素分泌剂.
- 它被广泛用作增强表现的补充剂.
- 报告的副作用包括,食欲增加和肌肉疼痛,肝毒性很少出现.
研究的目的:
- 报告与MK-677.7相关的药物诱导性肝损伤 (DILI) 的情况.
- 为了突出MK-677的肝毒性潜力,尽管它很罕见.
主要方法:
- 案例报告的呈现方式.
- 对临床表现和实验室发现的审查.
- 在停止补充后监测肝功能测试.
主要成果:
- 一名30多岁的健康男性患上肝酶升高 (透氨炎).
- 超氨基酸炎发生在MK-677消费两个月后.
- 在停止服用补充剂后,肝功能正常化.
结论:
- 尽管MK-677的使用很常见,但它可能与罕见的肝毒性病例有关.
- 临床医生应该考虑MK-677作为使用增强性能的补充剂的个体肝损伤的潜在原因.
- 需要进一步的研究来充分阐明MK-677的肝毒性潜力.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
385
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
385
Hepatic Drug Excretion: Influencing Factors
229
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
229
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K


